Piramal Pharma Limited — Others, 19-02-2025: Shareholders meeting

Piramal Pharma Limited has submitted a Postal Ballot Notice seeking shareholder approval to appoint Ms. Nathalie Leitch as a Non-Executive, Non-Independent Director, effective January 28, 2025. Ms. Leitch brings over 20 years of experience in the pharmaceutical industry, previously holding senior roles at major companies, contributing her expertise in commercial management, product strategy, and acquisitions. The remote e-voting for this resolution will commence on February 20, 2025, and conclude on March 21, 2025. This move is likely to foster a positive outlook among investors, reinforcing the board's strength and strategic direction.